NPSGX
Price
$22.60
Change
+$0.20 (+0.89%)
Updated
Jun 2 closing price
Net Assets
182.56M
WCMNX
Price
$14.98
Change
+$0.18 (+1.22%)
Updated
Jun 2 closing price
Net Assets
53.09M
Interact to see
Advertisement

NPSGX vs WCMNX

Header iconNPSGX vs WCMNX Comparison
Open Charts NPSGX vs WCMNXBanner chart's image
NPSGX vs WCMNX Comparison Chart in %
View a ticker or compare two or three
VS
NPSGX vs. WCMNX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPSGX is a Buy and WCMNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NPSGX has more cash in the bank: 183M vs. WCMNX (53.1M). NPSGX (0.00) and WCMNX (0.00) have matching dividends . NPSGX was incepted earlier than WCMNX: NPSGX (7 years) vs WCMNX (7 years). WCMNX (2.04) is less costly to investors than NPSGX (1.06). NPSGX is a more actively managed with annual turnover of: 147.00 vs. WCMNX (89.00). WCMNX has a lower initial minimum investment than NPSGX: WCMNX (1000) vs NPSGX (5000). NPSGX annual gain was more profitable for investors over the last year : 55.12 vs. WCMNX (25.42). NPSGX return over 5 years is better than : 15.76 vs. WCMNX (-1.40).
NPSGXWCMNXNPSGX / WCMNX
Total Expense Ratio0.991.2480%
Annual Report Gross Expense Ratio1.062.0452%
Fund Existence7 years7 years-
Gain YTD25.2809.225274%
Front LoadN/AN/A-
Min. Initial Investment50001000500%
Min. Initial Investment IRAN/AN/A-
Net Assets183M53.1M345%
Annual Yield % from dividends0.000.00-
Returns for 1 year55.1225.42217%
Returns for 3 years80.5331.21258%
Returns for 5 years15.76-1.40-1,126%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IILGX32.710.13
+0.40%
Thrivent Global Stock S
BLDRX9.740.01
+0.10%
BlackRock Managed Income K
RYENX313.96N/A
N/A
Rydex Energy A
FPACX45.31N/A
N/A
FPA Crescent
NSCCX43.02N/A
N/A
Nuveen Small-Cap Value Opps C